Purpose of Review At present, the most common diagnostic measures for the autoimmune neuromuscular disease myasthenia gravis (MG) are radioimmunoprecipitation assay (RIPA), enzyme-linked immunosorbent assay (ELISA), and cell-based assay (CBA). Considering the pitfalls of these diagnostic assays, this review describes the advantages of using Xenopus tissue cultures for MG diagnosis and research. Recent Findings Our recent study described a novel CBA involving Xenopus tissue cultures for MG serological diagnosis. Moreover, this CBA can potentially be applied to elucidate the pathogenic mechanisms underlying acetylcholine receptor endocytosis and degradation and to develop and validate potential therapeutic strategies for MG. Summary Although most CBAs are relatively labor intensive, Xenopus CBA is a promising tool for the initial clinical serological diagnosis and for the pathological research of MG. The future studies will be devoted to gain a better understanding of the etiology of MG and to provide a therapeutic intervention for this disease.
Introduction
The African clawed frog Xenopus is the leading vertebrate model for the study of gene function in embryonic development for the past 50+ years [1, 2] . Using a combination of various techniques, including molecular manipulation, cell lineage analysis, and live cell imaging, Xenopus offers an ideal platform for studies on the molecular and cellular controls of patterning formation, morphogenesis, and organogenesis during embryonic development. Remarkably, the wellestablished Xenopus primary cultures of nerve and muscle tissues have been used extensively to elucidate the cellular and molecular mechanisms of neuromuscular junction (NMJ) development [3, 4] . Embryonic Xenopus tissue cultures provide several unique advantages, including the feasibility of forming functional NMJs in vitro by co-culturing the muscle cells and spinal neurons (Fig. 1a, b) , overexpression of green fluorescent protein (GFP) fusion proteins or their mutant, and morpholino-mediated knockdown of a specific endogenously expressed protein that can be easily performed in early Xenopus embryos. Importantly, many findings originally discovered in the Xenopus system have been subsequently validated in the mammalian systems [5, 6] .
Myasthenia gravis (MG) is an acquired autoimmune disease of the NMJ with a prevalence of 200-300 per million population. MG is heterogeneous in terms of pathophysiology, which is determined by the pathogenic autoantibodies (autoAbs) targeting to synaptic proteins at the NMJs [7•] . Approximately 85% of generalized MG patients have autoAbs against the acetylcholine receptors (AChRs) in the postsynaptic muscle membrane [8] , and about 60% of the remaining patients have autoAbs against the muscle-associated receptor tyrosine kinase (MuSK) and LDL receptor-related protein 4 (LRP4) [9, 10] . In this review paper, we will describe our recently developed assay involving the use of Xenopus muscle or nerve-muscle cultures as an alternative cell-based assay (CBA) for MG diagnosis. Afterwards, we will highlight the strengths of Xenopus tissue cultures as a research platform to elucidate the pathogenic mechanisms underlying AChR endocytosis in MG patients and to develop potential therapeutic strategies by manipulating AChR endocytosis and degradation in MG pathogenesis.
Development of Functional NMJs in Embryonic Xenopus Nerve-Muscle Cultures
The NMJ is comprised of the presynaptic motor nerve terminal, the postsynaptic muscle membrane, and the terminal Schwann cell [11] . The basal lamina components at the synaptic cleft also contribute a crucial role in synaptic development. The study of NMJ development in tissue cultures is traceable back to the landmark discovery by Ross Harrison in 1907, in which he invented the "hanging drop" technique using the combined frog embryonic nerve fragments and lymphoid tissue to prepare explants on sterile coverslips [12] . This denotes the very first observation of nerve tissues that can be cultured, maintained, and grown outside the body. Anderson et al. have further developed the preparation of nerve-muscle co-cultures using dissociated tissues from early Xenopus embryos in the late 1970s [13] . They discovered that the formation of the NMJs in vitro can be reproducibly observed when the dissociated Xenopus spinal neurons and muscle cells are cultured together, as evidenced by the accumulation of AChRs at nerve-muscle contact sites after the labeling with fluorescent α-bungarotoxin (α-BTX) (Fig. 1b) . Moreover, by making successive observations on the same muscle cells, Fig. 1 Experimental approaches to examine the effects of autoantibodies in the MG patient's serum on the synaptic structure and function of the NMJs in vitro. a The dorsal part (dotted lines, highlighted regions in green) of a 1-day-old Xenopus embryo (at stage 22), which contains neural tube (NT), somite (S), and notochord (NC), is dissected and then subjected to enzymatic collagenase treatment. Somite tissues are dissociated and plated separately to prepare muscle cultures or together with neural tube tissues to prepare neuron-muscle co-cultures. b Left: spontaneously formed aneural AChR clusters (inset) are observed by live labeling the muscle cells with rhodamine-conjugated α-bungarotoxin (red). Right: in neuron-muscle co-cultures, nerve-induced AChR clusters (inset, arrows) are found to be spatially localized along the contact sites between neurons and muscle cells (dotted lines). Arrowhead points to the cell body of a spinal neuron. c Dissociated muscle cells (M) and spinal neurons (N) are plated on plain glass coverslips for electrophysiological recordings. Spontaneous synaptic currents (SSCs) are recorded from the innervated muscle cells of 1-day-old neuronmyoball co-cultures by the whole-cell patch-clamp technique. The effects of MG patients' serum samples on the synaptic structure and function of the NMJs can be examined by cellular imaging and electrophysiology approaches, respectively. Scale bars represent 20 μm Anderson and Cohen demonstrated the redistribution of fluorescently labeled AChRs upon synaptic induction [14] . Nerveinduced redistribution of AChRs is thus believed to be one of the initial steps in neuromuscular synaptogenesis. The development of functional NMJs after the initial establishment of a nerve-muscle contact was further supported by in vitro electrophysiological recordings on Xenopus nerve-muscle co-cultures [15] (Fig. 1c) . Similar to the NMJs in mammalian systems, the developmental transition of AChR subunit composition from γ-to ε-subunit is also detected at the Xenopus NMJs [16] , reflecting that the modulation of AChR channel properties during the developmentally regulated maturation of neuromuscular synapses is observed in both mammalian and Xenopus systems.
Regulation of AChR Trafficking and Clustering at Developing NMJs
The presence of a high density of AChR clusters at the postsynaptic membrane is the most prominent feature of the NMJs. Even prior to nerve innervation, AChRs are expressed and assembled in spontaneous clusters, called aneural AChR clusters, and in Xenopus muscle cultures and other muscle cell lines [5, 17] (Fig. 1b) . During the neuromuscular synaptogenesis, it is widely believed that the induction, assembly, and maturation of AChR clusters at the postsynaptic site are initiated by the stimulation of a nerve-derived heparan sulfate proteoglycan agrin (AGRN) [18] . Binding of agrin to LRP4 activates the MuSK that consequently causes AChR clustering through the cytoplasmic linker protein rapsyn, a receptorassociated protein of the synapse (RAPSN) [19] [20] [21] . In addition, agrin-induced MuSK activation causes dephosphorylation of aneural AChR clusters by tyrosine phosphatases, which eventually leads to the dispersal of aneural AChR clusters [22] . There are two non-mutually exclusive hypotheses that have been proposed to mediate redistribution of AChRs from extra-synaptic regions to the nascent postsynaptic sites for clustering. First, the diffusion-trap mechanism suggests that nerve-induced assembly of cytoskeletal scaffolds may act as a trap to recruit and/or stabilize the mobile AChR molecules that exhibit random Brownian motion in the muscle membrane surface [23] . Second, AChRs at the aneural cluster may be internalized, transported via the endocytic vesicles, and then reinserted to the synaptic sites by the vesicular trafficking mechanism. The recycling of internalized AChRs is a calcium-dependent process, mediated by calcium-activated calmodulin-dependent kinase II (CaMKII) activity [24] .
Both actin and microtubule cytoskeleton are shown to be crucial for vesicular trafficking and clustering of AChRs at the postsynaptic sites [25, 26] . Agrin activates a small GTPase Cdc42 that, in turn, regulates an Arp2/3 complex to promote actin polymerization through the activation of WiskottAldrich Syndrome protein (WASp) [27] . The postsynaptic stabilization of AChR clusters is achieved by the rapsynmediated linkage of the AChR to the cytoskeleton-anchored dystrophin-glycoprotein complex [28] . Apart from serving as a stable cytoskeletal scaffold for the docking and anchoring of structural and signaling molecules, our previous studies have provided definitive evidence to show that another dynamic pool of F-actin, regulated by actin depolymerizing factor (ADF)/cofilin, actively facilitates the site-directed delivery of AChRs to the nascent postsynaptic sites by modulating dynamic actin turnover locally. ADF/cofilin may break the cortical actin barrier for allowing the fusion of AChR-containing vesicles with the plasma membrane [5] . As for the involvement of microtubules for AChR clustering, a recent study has demonstrated that an increase in microtubule capturing leads to an increase in AChR density at the postsynaptic membrane [29] . Agrin inhibits the phosphorylation of serine residues of the microtubule plus end-tracking protein CLASP2. The phosphatidylinositol-3,4,5-triphosphate (PIP 3 )-binding protein LL5β promotes the binding of CLASP2 to microtubule plus ends in regulating microtubule capturing.
Pathogenic Mechanisms of AChR Endocytosis and Degradation in MG
MG is a prototypical autoimmune neuromuscular disease caused by the attack of autoAbs against some crucial postsynaptic proteins at the NMJs. It has been shown from the clinical data that around 85% of MG patients contain autoAbs against complex epitopes in different subunits of AChR, including cholinergic receptor nicotinic alpha 1 (CHRNA1), cholinergic receptor nicotinic beta 1 (CHRNB1), cholinergic receptor nicotinic delta (CHRND), cholinergic receptor nicotinic epsilon (CHRNE), and cholinergic receptor nicotinic gamma (CHRNG) ( Table 1) , which represent the most typical type of autoAbs in seropositive MG (SPMG) patients [30] . The pathogenic mechanisms underlying SPMG are relatively well characterized, including antigenic modulation, activation of complement system, and inhibition of AChR channel function [7•, 31•] (Fig. 2) . The antigenic modulation is initiated by the binding of autoAbs to antigens in AChR proteins, which induces receptor cross-linking and internalization and eventually leads to the loss of surface AChRs from the postsynaptic membrane ( Fig. 2(a) ). The reduced number of postsynaptic AChRs decreases the amplitude of nerve-evoked end-plate potentials, and thereby, the nerve signal is unlikely to initiate muscle contraction by depolarizing the muscle membrane potential beyond the threshold for generating an action potential. In addition, the direct binding of autoAbs occupies the ligand binding sites of AChRs, which prevents the activation of AChR from binding with ACh ligands released from the nerve terminal and leads to the inhibition of channel function ( Fig. 2(b) ). Regarding the activation of complement system, autoAbs against AChR belongs to an IgG1 subclass, consisting of bivalent Fc (fragment crystallizable region). This suggests that binding of IgG1 to AChR activates the classical complement system. Assembly of the membrane attack complex (MAC) triggers the influx of calcium ions that causes the destruction of postsynaptic membrane and junctional folds, as well as the lysis of muscle fibers (Fig. 2(c) ). Taken together, antigenic modulation, complement activation, and channel inhibition are the major pathological mechanisms of SPMG.
The remaining 15% of MG patients that do not have antiAChR autoAbs were initially considered as seronegative MG (SNMG) patients [30, 32, 33] ; however, a considerable amount of work has been carried out to search for novel antigenic reactivity in SNMG patients in the past decades. Now, more than half of the previously identified SNMG patients indeed pose autoAbs against MuSK. Unlike MG caused by autoAbs against AChR (AChR-MG), the pathogenic mechanism of autoAbs against MuSK (MuSK-MG) is not well understood. It is believed that the pathogenic subclass of autoAbs involved in MuSK-MG belongs to IgG4 [34] . The presence of monovalent Fc due to Fab (fragment antigen binding region) arm exchange making MuSK IgG4 follows a different immunological pathway to AChR depletion as in AChR-MG. This evidence suggests that the depletion of AChR caused by anti-MuSK autoAbs is not complement-related. It has been demonstrated that when the passive transfer of the MG patient-derived IgG with high titers of MuSK antibody into mice, there is an internalization of MuSK followed by a reduction in the density and cluster size of AChRs at the NMJs [32] . It is possible that the dimerization-induced MuSK activation by autoAbs leads to its depletion. However, the exact pathogenic mechanism is yet to be revealed. Apart from the autoAbs against MuSK, a growing list of autoAbs has been identified in those initially identified SNMG patients, which attack other synaptic proteins at the NMJs [7•] , including AGRN, LRP4, RAPSN, collagen-like tail subunit of % identity is the percentage of aligned amino acid sequences with the same residues at the same positions between Xenopus and human. All Xenopus and human protein sequences were retrieved from the online protein database at the National Center for Biotechnology Information (NCBI) asymmetric acetylcholinesterase (COLQ), cortactin (CTTN), potassium voltage-gated channel subfamily A member 4 (KCNA4), ryanodine receptor 1 (RYR1), and titin (TTN) ( Table 1) . With the identification of these novel autoAbs, the percentage of SNMG has now been dramatically reduced. Considering the high sequence homology of all these proteins between Xenopus and human (as summarized in Table 1 ), Xenopus tissue cultures offer an ideal assay for the study of autoAb-mediated pathogenic mechanisms underlying AChR endocytosis, trafficking, and degradation in MG pathogenesis.
Xenopus Cultures as an Alternative Cell-Based Assay for MG Diagnosis
In 1976, Lindstrom et al.'s group firstly described a serological assay for MG diagnosis by detecting the presence of antiAChR autoAbs with radioimmunoprecipitation assay (RIPA) [35] . In short, radioactive α-BTX molecules are added to bind with AChR proteins in human muscle extracts that serve as antigens for autoAbs. After incubating the patient's serum containing potential pathogenic autoAbs, co-precipitation is performed with the anti-human IgG antibodies. Radioactivity of the pellets indicates the presence of antiAChR autoAbs in the patient's serum sample. An alternative approach is enzyme-linked immunosorbent assay (ELISA), which was first adopted for MG diagnosis in 1984 [36] . In this assay, recombinant AChR proteins are coated on a flatbottom microtiter plate, follow by the incubation of the patients' serum samples. The color given out by the reaction between peroxidase-conjugated anti-human IgG and the substrate indicates the presence of autoAbs against AChR in the serum sample. As the recombinant AChR proteins are in solution phase, some autoAbs against clustered AChR may not be detected in RIPA [37] . Besides, insufficient blocking may also give false positive results in ELISA. Despite RIPA and commercial ELISA kits have been widely adopted for MG diagnosis, their sensitivity is questionable. A more sensitive approach using the CBA is therefore developed. It has been shown that 66% of serum samples from previously identified SNMG patients indeed contain lowaffinity AChR-binding IgG against clustered AChR when CBA was used as the serological test [38••] . Co-expression of complementary DNA sequences encoding AChR and the anchoring protein, rapsyn, in human embryonic kidney (HEK) cells mimics the postsynaptic specializations of the NMJ in vivo where AChRs are highly concentrated. The presence of autoAbs in the patient's serum sample is then determined by immunocytochemistry. In comparison to RIPA and ELISA, CBA is considered as a more reliable approach for MG diagnosis [38••] , which allows the expression of AChR proteins in a cellular environment to enable the localization and clustering of AChRs at a high density in anchorage to membrane surface via rapsyn. This apparently improves the sensitivity of detecting the binding of low reactivity autoAbs against clustered AChRs.
Apart from using heterologous cell lines, our recent study described the use of Xenopus tissue cultures as an alternative CBA for MG diagnosis and research [39••] . We were able to use Xenopus tissue cultures to detect the pathogenicity of serum samples from both SPMG and SNMG patients, as evidenced by a significant reduction of aneural and nerveinduced AChR clusters after incubating with the MG patients' serum samples (Fig. 1b) . The interaction between autoAbs in the serum samples from MG patients and proteins in the postsynaptic apparatus would cause the endocytosis and disassembly of aneural and nerve-induced AChR clusters in pure muscle cultures and nerve-muscle co-cultures, respectively. Apart from the cell imaging approach to quantify the effects of MG serum on AChR cluster dispersal, Xenopus neuron-myoball co-cultures can also be employed to test the effects of the MG patients' serum samples on synaptic functions of the NMJs by in vitro electrophysiological recordings (Fig. 1c) . Spontaneous synaptic currents (SSCs) can be measured by the whole-cell patch-clamp recording method on 1-day-old neuron-myoball co-cultures before and after the incubation of the MG patients' serum samples. The change in SSC frequency and/or amplitude implicates the effects of MG serum on presynaptic and/or postsynaptic inhibitions of neuromuscular functions, respectively. Hence, the possibility of assessing the structural (cell imaging approach) and functional (electrophysiology approach) defects of the NMJs after the treatment of pathogenic MG serum samples in Xenopus tissue cultures infers their potential to be used as an alternative CBA in MG diagnostic practice.
One might argue on the feasibility of translating the knowledge obtained from the Xenopus model into our understanding of human diseases. As shown in the recent completion of sequencing data, the Xenopus genome shares a high level of spatial and functional collinearity of genes with humans [40] . Xenopus is well positioned between distant invertebrates, like the fruit fly (Drosophila) and the worm (Caenorhabditis elegans), and the less-accessible mammalian models [41] . Importantly, we have found that the amino acid sequence of some postsynaptic proteins in association to the MG pathogenesis shows a high degree of similarities between Xenopus and human (Table 1) . For instance, the amino acid sequences of AChR α1 subunit (CHRNA1), the ACh-binding subunit of AChR, in Xenopus tropicalis and Xenopus laevis share 74 and 73% similarity to those in human, respectively. Another important postsynaptic protein, MuSK, also shows more than 80% sequence homology between Xenopus species and human. Taken together, this gives a strong argument that Xenopus tissue culture is an ideal platform for the serological diagnosis and the pathological research of MG.
In Search of Therapeutic Strategies for the Treatment of MG Using Xenopus Tissue Cultures
Many potential strategies have been identified to alleviate the symptoms of muscle weakness after the onset of MG [7•] . One of the most commonly used medications is the reversible acetylcholinesterase (AChE) inhibitor, pyridostigmine [42] . The increased level and duration of neurotransmitter acetylcholine by inhibiting AChE activity at the synaptic cleft can alleviate muscle weakness in MG patients. However, the transient and mild effects of AChE inhibition are insufficient to treat MG [43] and may also contribute to various side effects, such as muscarinic overactivity, nicotinic side effects, and cholinergic crisis state [44] . Other common treatments to MG also include the immunosuppressant drug, plasmapheresis, immunoglobulin therapy, and thymectomy [7•] . These treatment strategies, however, cannot give a complete remission for MG patients, which urges the development of advanced therapeutic approaches for MG treatment in the future.
At the mature NMJs, it has long been believed that AChRs are metabolically stable in the postsynaptic membrane at the mature NMJs, until they are internalized and targeted to lysosomes for protein degradation [45] . In fact, some internalized AChRs are recycled and inserted back to the postsynaptic membrane for maintaining a high postsynaptic AChR density [24, 46] . Using biotin-α-BTX and streptavidin conjugates of different fluorophores, it is possible to distinguish various pools of AChRs, namely preexisting, recycling, and newly synthesized AChRs [46, 47] . This sequential labeling approach will allow us to investigate the trafficking mechanisms of endocytosed AChR vesicles following endocytosis. Our long-term goal is to develop a potential therapeutic strategy that alleviates the loss of AChRs at the NMJs in MG pathogenesis. One of the possible therapeutic approaches is to manipulate the trafficking and stability of synaptic AChR clusters. Given the fact that the loss of AChR clusters is triggered by autoAb-induced cross-linking followed by endocytosis of AChRs, a therapeutic strategy can be developed to modulate the rate of AChR endocytosis and/or to regulate the recycling of endocytosed AChRs, so as to maintain the high density of AChR clusters for efficient neurotransmission between motor neurons and muscle fibers. Our recent studies using Xenopus muscle cells have demonstrated the spatial and temporal correlations between ADF/cofilin localization and the clustering of AChRs at the developing NMJs [5] . We also observed the disassembly of AChR clusters and the disappearance of ADF/cofilin localization upon the treatment of the MG patients' serum samples, suggesting that pathogenic autoAbs regulate ADF/ cofilin localization and function for the dispersal of AChR clusters [39••] . It is of interest to further investigate if manipulating the activity of ADF/cofilin or its upstream regulators could inhibit the endocytosis and degradation of AChR clusters in response to MG serum treatment.
Our recent study reported a procedure to mimic the pathogenic autoAbs for inducing the cross-linking and endocytosis of AChRs in Xenopus tissue cultures [48•] . In that study, we took advantage of the multivalent interaction between biotin and streptavidin to cross-link the biotin-α -BTX-labeled AChR molecules by streptavidin-conjugated quantum dots (QDs) (Fig. 2(d) ). QDs are nanometer-sized semiconductor particles that are much brighter and more stable than traditional organic fluorescent probes, which allow us to visualize and perform long-term tracking of internalized AChR vesicles upon receptor cross-linking-induced AChR endocytosis. The unique features of QDs, which include the direct relationship between the QD-emitted wavelength of fluorescence emission and its size, the multicolor imaging from wide excitation and narrow emission range, and the possible detection of QDs in transmission electron microscopy (TEM) without chemical staining [49] , offer a powerful tool for single-molecule imaging and tracking. By using correlative light and electron microscopy (CLEM) [50] , high-resolution correlative microscopy images can be acquired to characterize the particular subcellular structures in association with the endocytic trafficking and lysosomal degradation pathways of endocytosed AChRs upon the cross-linking action by streptavidin-QDs. Therefore, QDs can be employed not only to visualize and track the surface movement of AChRs during the formation of synaptic AChR clusters in live muscle cells [51] , but also, the multivalent interaction between biotin and streptavidin allows us to track the internalized AChR vesicles following the crosslinking-induced endocytosis [48•] . As this cross-linking effect mimics the antigenic modulation, one of the pathogenic mechanisms of autoAbs that induce internalization of cross-linked AChR clusters in MG patients, a possible treatment may be developed to interfere the clathrin-mediated endocytic pathway, which has been implicated to regulate the cross-linking-induced AChR endocytosis in cultured muscle cells [48• ]. Therefore, the reduced level of antigenic modulation should prevent the loss of AChR clusters in postsynaptic membrane. Taken together, Xenopus tissue cultures offer a simple in vitro assay to study and manipulate the pathogenic mechanisms in MG.
Conclusion
In light of the potential pitfalls of all current diagnostic assays described above, it is essential to develop a more reliable, sensitive, and specific tool for the diagnosis of MG, even at the early stage of pathogenesis. Although most CBAs are relatively labor intensive, the Xenopus tissue culture-based serological test is a promising tool for the initial clinical diagnosis of MG by testing autoAb pathogenicity in vitro. This assay can also be employed to distinguish the disease severity among different patients and to monitor the course of the disease and the efficacy of treatment received for a particular MG patient. Additionally, Xenopus tissue cultures provide an important research platform for elucidating the pathogenic mechanisms underlying AChR endocytosis in both seropositive and seronegative MG patients. Therefore, results of these studies using Xenopus tissue cultures should contribute to a better understanding of the etiology of MG and provide a therapeutic intervention for this malady in the future.
